A Study to Assess Safety and Efficacy of CHO-H01 in Subjects With Refractory or Relapsed Non-Hodgkin's Lymphoma

Condition:   Non-Hodgkin Lymphoma Intervention:   Biological: CHO-H01 Sponsor:   Cho Pharma Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials